Promomed entered the TOP-20 leading Russian manufacturers according to Forbes
Promomed 27 August 2021
The Biokhimik production complex, which is part of the Promomed Group, took 6th place in the Forbes rating of the leading Russian drug manufacturers.
The TOP-20 includes the largest companies in terms of revenue for 2020, which are classified in the SPARK system under category «Production of drugs and materials used for medical purposes».
Companies were rated according to six criteria: revenue for 2020, change in revenue for the year, net profit, change in profit for the year, number of company’s drugs with marketing authorization, and number of approvals to conduct clinical trials.
Companies were rated according to six criteria: revenue for 2020, change in revenue for the year, net profit, change in profit for the year, number of company’s drugs with marketing authorization, and number of approvals to conduct clinical trials.
Forbes №09 (210) 2021
Promomed entered the TOP-20 leading Russian manufacturers according to Forbes
